Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia - update of single center study.
Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E, Szotkowski T, Rohon P, Hubacek J, Indrak K, Pikalova Z, Jarosova M, Divoka M, Langova K, Papajik T. Raida L, et al. Among authors: rusinakova z. Neoplasma. 2017;64(5):762-769. doi: 10.4149/neo_2017_515. Neoplasma. 2017. PMID: 28592129
Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression could be an effective approach to patients with acute lymphoblastic leukemia.
Raida L, Rusinakova Z, Szotkowska R, Kuba A, Faber E, Rohon P, Szotkowski T, Hubacek J, Pikalova Z, Jarosova M, Divoka M, Indrak K, Langova K, Skoumalova I, Papajik T. Raida L, et al. Among authors: rusinakova z. Neoplasma. 2015;62(5):805-11. doi: 10.4149/neo_2015_097. Neoplasma. 2015. PMID: 26278139
Reduced relative dose intensity of primary chemotherapy does not influence prognosis of patients with Hodgkin lymphoma.
Raida L, Papajik T, Rusinakova Z, Prochazka V, Faber E, Cahova D, Tucek P, Indrak K. Raida L, et al. Among authors: rusinakova z. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014 Sep;158(3):428-32. doi: 10.5507/bp.2013.022. Epub 2013 Apr 10. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014. PMID: 23579110 Free article.
Comparison of new flu-bu12-tg conditioning with the standard bu-cy myeloablative regimen in patients undergoing allogeneic stem cell transplantation for acute myeloid leukemia.
Raida L, Tucek P, Faber E, Vondrakova J, Rusinakova Z, Skoumalova I, Hubacek J, Jarosova M, Katrincsakova B, Pikalova Z, Kurfurst P, Indrak K. Raida L, et al. Among authors: rusinakova z. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Dec;155(4):327-32. doi: 10.5507/bp.2011.040. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011. PMID: 22336644
Identification of e6a2 BCR-ABL fusion in a Philadelphia-positive CML with marked basophilia: implications for treatment strategy.
Rohon P, Divoka M, Calabkova L, Mojzikova R, Katrincsakova B, Rusinakova Z, Lapcikova A, Raida L, Faber E, Jarosova M, Divoky V, Indrak K. Rohon P, et al. Among authors: rusinakova z. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Jun;155(2):187-90. doi: 10.5507/bp.2011.030. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011. PMID: 21804629 Free article.
Long-term outcome of patients with peripheral T-cell lymphoma treated with first-line intensive chemotherapy followed by autologous stem cell transplantation.
Prochazka V, Faber E, Raida L, Papajik T, Vondrakova J, Rusinakova Z, Kucerova L, Myslivecek M, Indrak K. Prochazka V, et al. Among authors: rusinakova z. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Mar;155(1):63-9. doi: 10.5507/bp.2011.009. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011. PMID: 21475380 Free article.